Clinical Trial Update: Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is recruiting and compares blinatumomab alternating with low-intensity chemotherapy against standard-of-care chemotherapy in older a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Chemotherapy (low-intensity or standard-of-care) (low-intensity chemotherapy)

Snippet

Sponsor: Amgen | Conditions: Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Status: RECRUITING